Biologic characterization of atypical chronic lymphocytic leukaemia

Dina S Soliman; Einas Al-Kuwari; Rajaa Al-Abdulla; Prem Chandra; Abdulqader Nashwan; Feryal A Hilmi

doi:10.1111/ijlh.13645

Biologic characterization of atypical chronic lymphocytic leukaemia

Int J Lab Hematol. 2022 Feb;44(1):e49-e51. doi: 10.1111/ijlh.13645. Epub 2021 Jul 5.

Authors

Dina S Soliman^{1

2

3}, Einas Al-Kuwari⁴, Rajaa Al-Abdulla⁴, Prem Chandra⁵, Abdulqader Nashwan⁶, Feryal A Hilmi¹

Affiliations

¹ Department of Laboratory Medicine and Pathology, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
² Weill Cornell Medical College-Qatar (WCMC-Q), Doha, Qatar.
³ Department of Clinical Pathology, National Cancer Institute, Cairo, Egypt.
⁴ Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
⁵ Medical Research Center, Academic Health Systems, Hamad Medical Corporation, Doha, Qatar.
⁶ Nursing Department, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.

PMID: 34224207
DOI: 10.1111/ijlh.13645

No abstract available

Keywords: CD20; CD43; atypical CLL; chronic lymphocytic leukaemia (CLL); flow cytometry; immunohistochemistry; lymphoid enhancer-binding factor 1 (LEF-1).

Publication types

Letter
Comment

MeSH terms

Biological Products*
Humans
Immunophenotyping
Leukemia, Lymphocytic, Chronic, B-Cell*
Lymphoid Enhancer-Binding Factor 1

Substances

Biological Products
Lymphoid Enhancer-Binding Factor 1